Non-Oncology Applications: 10 of 14
Metabolic Disease
Metabolic disease covers problems in how the body handles energy, including obesity, insulin resistance, type 2 diabetes, abnormal blood fats, and the buildup of fat in the liver.
This is another area where ordinary blood tests already do a lot of the work. Glucose, cholesterol, and measures of average blood sugar over recent months are cheap, familiar, and widely available. Most metabolic conditions can already be diagnosed and monitored without anything more complicated.
The questions for newer liquid biopsy methods are therefore narrower. Many metabolic diseases develop slowly over years before a person crosses the line into a formal diagnosis. Even among people who look similar on standard tests, some will develop complications and others will not. Two people with the same weight, for example, can have very different amounts of fat in the liver and very different risks from it. Measuring liver fat directly may still require imaging or a biopsy.
Researchers study short RNA pieces, some of which come mainly from fat tissue or the liver, as well as packages of material released by cells, patterns across circulating proteins, small molecules involved in metabolism, and cell-free DNA as a broader sign of tissue stress. There is also a lot of interest in signals linked to the bacteria living in the gut, since those bacterial communities differ in people with metabolic disease.
Everyday behavior can move these measurements substantially. What someone ate, when they ate it, how much they slept, and whether they exercised that morning can all change the result. Sometimes those effects are larger than the disease signal itself. Sample collection has to be tightly controlled, and differences between studies may partly reflect differences in how people were sampled.
Time is another challenge. If the goal is to show that a marker predicts future diabetes or liver damage, researchers have to follow people for years. The new marker also needs to add something beyond information that is already easy to collect, such as weight, waist size, blood pressure, and family history.
In this index: 789 of the classified papers and patents concern metabolic disease.
This page explains what these tests are and how researchers use them. It is not medical advice, and it is not a guide to whether any test is right for you or for a patient. Talk to a clinician about testing decisions.